Back to results
US 10,046,011 B2Granted
Compositions for inducing or suppressing an immune response
AssigneeRutgers, The State University of New Jersey
InventorsYufang Shi, Guangwen Ren, Liying Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides methods or kits with inflammatory cytokines to pretreat 1-ISCs to augment their immune modulatory effect, in prevention and treatment of various diseases such as multiple sclerosis, arthritis, lupus, sepsis, hepatitis, cirrhosis, Parkinson's disease, chronic infections, and GvHD. The present invention relates to novel methods for enhancing the immunosuppressive or the immune stimulatory activities of mesenchymal stem cells (JvfSCs).
Claims2
A composition comprising
- (a) a population of isolated mesenchymal stem cells produced by a method comprising the steps of :
- (i) obtaining multipotent progenitor cells;
- (ii) culturing said multipotent cells in a medium to produce a subpopulation of mesenchymal stem cells and a subpopulation of differentiated cells;
- (iii) separating mesenchymal stem cells from differentiated cells in said medium;
- (iv) treating the mesenchymal cells with functional Type 1 interferon α (IFN-I α) or transducing the mesenchymal stem cells to release functional IFN-I α;
- and
- (v) activating at least a subset of said separated mesenchymal stem cells with interferon gamma (IFNγ) and at least one cytokine selected from the group consisting of interleukin-1 alpha (IL-1 α), interleukin-1 beta (IL-1 (β), tumor necrosis factor alpha (TNF α), Type 1 interferons (IFN-I), transforming growth factor β(TGFβ), and fibroblast growth factor (FGF) for a sufficient period of time such that the activated mesenchymal stem cells are immunomodulatory.
4 more elements
Dependencies are inferred from the claim text.